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I.	 Project Title:	 Influence of Nanosilver Surface Charge on Cytotoxic Efficacy against Cancer Cells 
II.	 Project Completion Date:	 7 June, 2017 
III.	 Student(s),	 Department(s),	and Major(s) 
(1) Elliot Frey: B.S. Materials Engineering, Biology minor
IV.	 Faculty	 Advisor and	 Department 
Amro El Badawy, Civil and Environmental Engineering Department
Team Members:
• Sandra Clement, Cal Poly Biology Department
• Alice Hamrick, Cal Poly Biology Department 
• Kevin Dunham, Cal Poly Chemistry Department
V.	 Cooperating Industry, Agency, Non-Profit,	or 	University Organization(s) 
Jennifer Vanderkelen, Cal Poly Center for Applications in Biotechnology (CAB)
VI.	 Executive Summary 
Silver and silver-based products are known to cause cytotoxic effects to both microbes and eukaryotic cells.
Because of this property, silver nanoparticles (AgNPs) are being studied for their potential in targeted tumor
treatments. Previous studies with microbes suggest that AgNPs with cationic capping agents possess
enhanced cytotoxicity by virtue of Coulombic attraction between the nanoparticle and the negatively-charged
cell wall. Since animal cells possess similar negatively-charged plasma membranes, this research
hypothesized that human cells would be more susceptible to positively-charged AgNPs than to negatively-
charged AgNPs. To investigate this hypothesis, cancerous cervical cells (HeLa) and healthy fibroblast cells
(3T3) were subjected to treatments of 40 nm diameter AgNP with branched polyethylenimine (AgBPEI, ζ = + 
69 mV) and citrate (AgCit, ζ = - 49 mV) capping agents. AgNO3 was also tested to compare AgNP toxicity to
that of ionic silver (Ag+). An alamarBlue® viability assay was used to quantify the cytotoxicity of the
treatments relative to an untreated control group.
AgBPEI displayed a lower LD50 (median lethal dose) than both Ag+ and AgCit to both cell lines. This
suggests AgNP toxicity is not solely from Ag+ dissolution, and also ostensibly supports the initial hypothesis
(compared to AgCit, AgBPEI was approximately 84% more cytotoxic to HeLa cells and about 65% more 
cytotoxic to fibroblast cells). However, significant AgCit aggregation was observed in culture media, which
obfuscates surface charge-based toxicity effects because larger diameter AgNPs are less cytotoxic. In this
way, size-dependent toxicity must also be considered. While this does not allow for conclusions regarding the
              
       
       
        
 
            
              
               




     
 
               
 
 
           
 
 
              














   
    
     
   
   
   
   
 
   
 
   
  
 
 	 	 	 	
            
         
        
sole influence of surface charge, and therefore the hypothesis cannot be directly supported, results do not
negate its validity.  Ultimately, since AgBPEI is more stable than AgCit under in vitro conditions and is more 
prone to Coulombically interact with cancer cells, researchers investigating AgNPs for targeted tumor 
treatments should utilize AgBPEI over AgCit on the premise of enhanced bioavailability.
This research will continue over the summer of 2017 to retest AgBPEI against a negatively-charged AgNP
that is stable in test media. To this end, a silver nanoparticle coated with carboxyl (lipoic acid, ζ < 0 mV) has
been ordered. This would isolate surface charge as the only independent variable and eliminate aggregation
effects as a source of error, thus allowing for verification of the existing hypothesis.
VII. Major Accomplishments 
(1) AgBPEI displayed enhanced toxicity over AgCit to both cancerous and healthy mammalian cells. 
(2) AgCit agglomerated in test media, revealing AgBPEI is more stable at physiological pH and in vitro
conditions. 
(3) It was found that AgBPEI is a superior nanoparticle candidate over AgCit for targeted tumor research on 
the premise of enhanced bioavailability. 
(4) AgBPEI’s LD50 was lower than Ag+ for both cell lines. This suggests AgNP toxicity is not solely from
Ag+ dissolution, and that physical toxicity mechanisms exist between AgNPs and the cell.
VIII. Expenditure of	 Funds	 
Prior Expenses
(1) AgCit, 1 mg/mL, 2 mL
(2) AgBPEI, 1 mg/mL, 2 mL
(3) alamarBlue®, 25 mL
(4) Corningstar 96-well plates
(5) Triethylamine, 250 g
(6) Sodium Chlorite (s), 2 kg
Total Expenditures before 6/14/17: = $1341.54
Ordered for continuation of research (6/14/17):
(7) Serological pipets 5 mL individually wrapped 200/case x 1
(8) Serological pipets10 mL individually wrapped 200/case x 1
(9) DMEM Media, 10/500 mL x 1
(10) Trypsin/EDTA Solution, 100 mL
(11) Ag(Lipoic Acid), 1 mg/mL, 1 mL
(12) Ferrite Nanoparticles, 20 mg/mL, 10 mL
Order Estimate (including tax and shipping) : = $692.12
Total Expenditures (approximate): = $𝟐𝟎𝟑𝟑. 𝟔𝟔
IX. Impact on Student Learning	 
The primary takeaway from this research was first-hand experience in the field of nanotoxicology. The
student learned and applied tissue culturing techniques, ran dye-based viability assays, quantified and 
statistically analyzed cytotoxicity trends, modeled nanoparticle aggregation, and became familiar with 
           
          
academic grade research protocols. This study reflects the hands-on focus of the Cal Poly undergraduate
experience and the interdisciplinary ideals of the Baker and Koob Endowment.
